Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juan C, Arjona Ferreira"'
Publikováno v:
F&S Reports, Vol 4, Iss 2, Pp 73-82 (2023)
Treatment of uterine fibroids (UF) and endometriosis (EM) has relied on the surgical skills of gynecologists to improve symptoms and potentially alter the course of these debilitating diseases. Medical management of symptoms for both diseases leverag
Externí odkaz:
https://doaj.org/article/26807647b5644fc9ac888269487c4f3d
Autor:
Linda C, Giudice, Sawsan, As-Sanie, Juan C, Arjona Ferreira, Christian M, Becker, Mauricio S, Abrao, Bruce A, Lessey, Eric, Brown, Krzysztof, Dynowski, Krzysztof, Wilk, Yulan, Li, Vandana, Mathur, Qurratul Ann, Warsi, Rachel B, Wagman, Neil P, Johnson
Publikováno v:
The Lancet. 399:2267-2279
Endometriosis is a common cause of pelvic pain in women, for which current treatment options are suboptimal. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, combined with estradiol and a progestin, was evaluated for treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ef8b035e5b8ac6678ca47b337a6a377
https://doi.org/10.1016/s0140-6736(22)00622-5
https://doi.org/10.1016/s0140-6736(22)00622-5
Autor:
Ayman Al-Hendy, Andrea S Lukes, Alfred N Poindexter, Roberta Venturella, Claudio Villarroel, Hilary OD Critchley, Yulan Li, Laura McKain, Juan C Arjona Ferreira, Andria GM Langenberg, Rachel B Wagman, Elizabeth A Stewart
Publikováno v:
Pain Management.
What is this summary about? This is a summary of research studies (known as clinical trials) called LIBERTY 1 and LIBERTY 2. The LIBERTY 1 and LIBERTY 2 studies looked at how well a medication called relugolix combination therapy worked to reduce hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d59d24885a11133e79ddb224aed2915
https://doi.org/10.2217/pmt-2022-0085
https://doi.org/10.2217/pmt-2022-0085